How many investments has InFocus Capital Partners, LLC made?

InFocus Capital Partners, LLC has 6 tracked investments.

What stage does InFocus Capital Partners, LLC invest at?

InFocus Capital Partners, LLC invests at the Seed, Series A stages.

What sectors does InFocus Capital Partners, LLC focus on?

InFocus Capital Partners, LLC focuses on Biotech, Digital Health, Healthtech, Medical Devices.

Where is InFocus Capital Partners, LLC located?

InFocus Capital Partners, LLC is headquartered in Jericho, US.

InFocus Capital Partners, LLC

Venture capital

Jericho · Seed–Series A · 18 people tracked

Also known as InFocus

★ Follow + Add to CRM ⤳ Find an introduction

Find your way into InFocus Capital Partners, LLC

Paths you didn't know you had: your email and LinkedIn already hold routes to the InFocus Capital Partners, LLC team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict

Investment thesis

InFocus Capital Partners specializes in sourcing, capitalizing, and developing disruptive life sciences opportunities with a specific focus on ophthalmic innovation. The firm combines real-world clinical ophthalmic expertise with venture investment experience, leveraging a partnership structure and deep coverage of the ophthalmology field to identify differentiated opportunities and improve the probability of successful returns.

Invests inBiotech Digital Health Healthtech Medical Devices United States

Source: firm website, verified Aug 3, 2026.

Leave your own feedback

Stage

Seed–Series A

Jericho, New York, US

Instruments

Equity

Founded

2016

Tracked investments

Team · 18 people

from the firm's website & public directories

Robert L. Avery· Founder, California Retina Consultants & California Retina Research Foundation

Advisory board member and founder of California Retina Consultants and the California Retina Research Foundation.

George Marinopoulos· General Partner

Robert Rothman· General Partner

Ronald Weiss· General Partner

Rob Rothman· Founding Partner & Principal· New York City Metropolitan Area

Physician with roughly twenty years of experience in venture capital deal sourcing, diligence, and funding. Serves on the boards of Alievio, Cellview Imaging, Galimedix, and QURA, and is a Clinical Assistant Professor of Ophthalmology at Hofstra Northwell School of Medicine.

rrothman@infocuscapitalpartners.com

Ron Weiss· Founding Partner & Principal· United Statesin

Physician with over twenty years of venture capital experience and co-founder of Prescient Capital Partners. Founder of Chicago Eye Consultants and serves on multiple boards including Cellview Imaging, ONL, 2C Tech, Re-Vana, and Visibly.

rweiss@infocuscapitalpartners.com

Aron Shapiro· Senior Vice President, Asset Development & Partnering, Ora, Inc.

Advisory board member and SVP of Asset Development & Partnering at Ora, Inc.

Charles C. Wykoff· Director of Research, Retina Consultants of Houston

Advisory board member, Director of Research at Retina Consultants of Houston, and Deputy Chair of Ophthalmology for the Blanton Eye Institute.

David L. Katz· Medical Advisor, PL Developments

Advisory board member serving as Medical Advisor at PL Developments.

Donald Fishbein· President, Evolve Therapeutics

Advisory board member and President of Evolve Therapeutics.

Jeffrey M. Liebmann· Vice-Chair & Director of the Glaucoma Division, Department of Ophthalmology, Columbia University Medical Center

Advisory board member and Vice-Chair and Director of the Glaucoma Division at Columbia University Medical Center.

Jeffrey Smith· CEO & Chief Investment Officer, Starboard Value LP

Advisory board member and CEO and CIO of Starboard Value LP.

Jodi Luchs· Chief Science Advisor

InFocus Capital Partners Chief Science Advisor and Co-Medical Director of Eyevance Pharmaceuticals.

Matt Chapin· Senior Vice President, Asset Development & Partnering, Ora, Inc.

Advisory board member serving as SVP of Asset Development & Partnering at Ora, Inc.

Parag A. Majmudar· President & Chief Medical Officer, Chicago Cornea Consultants, Ltd.

Advisory board member and President and Chief Medical Officer of Chicago Cornea Consultants.

Philip Ferrone· Managing Partner & Director of Clinical Research, Long Island Vitreoretinal Consultants

Advisory board member and Managing Partner and Director of Clinical Research at Long Island Vitreoretinal Consultants.

Steven I. Rosenfeld· President, Delray Eye Associates

Advisory board member, President of Delray Eye Associates, Executive Advisor at Blue Sea Capital, and Chair of Ophthalmology at Modernizing Medicine.

Stuart Abelson· CEO & Managing Partner, Ora ADG (a division of Ora, Inc.)

Advisory board member; leads Ora ADG, a division of Ora, Inc.

What they invest in

from 6 of 6 portfolio companies

Biotech ×3Healthtech ×3AI & Machine Learning ×2Data & Infrastructure ×2Medical Devices ×2Crypto & Web3 ×1

HQs:United States×4

Investments · 6 tracked

founders shown can be your intro path

By year:2022 · 2 2019 · 1 2018 · 14 dated

ONL Therapeuticsonltherapeutics.com in✓ verified

ONL Therapeutics is a clinical-stage biopharmaceutical company developing therapies to preserve sight by preventing Fas-mediated death of retinal cells, a cause of vision loss and blindness.

BiotechHealthtechMedical DevicesAnn Arbor, US

David Zacks(Co-Founder & Chief Scientific Officer)in David Esposito(Executive Officer, Director)inConstance Chang(Executive Officer)John K Freshley(Executive Officer, Director)in Jeffrey A Jamison(Executive Officer)in

Board Aaron Fletcher(Director)in

Co-investorsExSight Ventures Invest Michigan Novartis Venture Fund Visionary Ventures Bios Partners Johnson & Johnson Innovation – JJDC +3 more

Trefoil Therapeuticstrefoiltherapeutics.com in✓ verified

Trefoil Therapeutics is a clinical-stage biotechnology company developing therapeutic agents for corneal diseases.

BiotechHealthtechMedical DevicesSan Diego, US

David Eveleth(Executive Officer, Director)in Schalon Newton(Executive Officer)in

Board Christy Shaffer(Director)inRalph Bradshaw(Director)

Co-investorsExSight Ventures Hatteras Venture Partners Solasta Ventures Access Biotechnology Bios Partners Correlation Ventures +1 more

2C Tech2ctechcorp.comDec 2019

HealthtechIrvine, US

JAMES TAYLOR(Executive Officer)IRVING ROBERT ARMSTRONG(Executive Officer)ROBERT SHIMIZU(Executive Officer)NARESH MANDAVA(Director)

BoardAKITERU FURUKAWA(Director)CLAUDE BENEDICT(Director)

Co-investorsExSight Ventures

Camras Visioncamrasvision.com 𝕏Apr 2018 · $5.7M

Based in Research Triangle Park, NC

BiotechResearch Triangle Park, US

Lucinda Camras(Executive Officer, Director, Promoter)inRoberto Alfaro(Executive Officer, Director)Ray Krauss(Executive Officer, Director)

BoardRobert Rothman(Director)

Co-investorsCharlotte Angel Fund Hatteras Venture Partners VCapital

Vanavana.org 𝕏Nov 2022 · $11.9M

Vana is an open data infrastructure platform that enables individuals to control and manage the data they generate, with the ability to choose how it is used by AI systems.

AI & Machine LearningData & Infrastructure

Art Abal(Founder)Anna Kazlauskas(Founder)

Co-investorsAbstract Ventures AlphaLab Capital Caladan Earl Grey Capital Paradigm SCB 10X +10 more

Vanavana.xyz 𝕏Dec 2022 · $11.9M

Vana provides open data infrastructure for AI that lets individuals control the data they create and choose how it is used.

AI & Machine LearningCrypto & Web3Data & Infrastructure

Art Abal(Founder)

Co-investorsBoxGroup Flori Ventures Coinbase Ventures DeFiance Capital ExSight Ventures GSR +8 more

Frequently asked questions

How many investments has InFocus Capital Partners, LLC made?: InFocus Capital Partners, LLC has 6 tracked investments.
What stage does InFocus Capital Partners, LLC invest at?: InFocus Capital Partners, LLC invests at the Seed, Series A stages.
What sectors does InFocus Capital Partners, LLC focus on?: InFocus Capital Partners, LLC focuses on Biotech, Digital Health, Healthtech, Medical Devices.
Where is InFocus Capital Partners, LLC located?: InFocus Capital Partners, LLC is headquartered in Jericho, US.

Similar investors

Amadeus Capital Partners

Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.

$50K – $12.7M

B Capital Group

B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.

$10M – $50M

Breyer Capital

Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.

$500K – $10M

Canaan Partners

Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.

$500K – $20M

Capricorn Venture Partners

Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.

$270K – $10.8M